These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


143 related items for PubMed ID: 4660543

  • 1. Laboratory testing of combined diphtheria-tetanus-pertussis-typhoid vaccines.
    Csizér Z, Joó I, Réthy L, Juhász VP.
    Prog Immunobiol Stand; 1971; 5():394-8. PubMed ID: 4660543
    [No Abstract] [Full Text] [Related]

  • 2. Biological standardization of potency testing of diphtheria-tetanus-pertussis vaccines.
    Csizér Z, Zsidai J.
    Ann Immunol Hung; 1979; 19():53-74. PubMed ID: 552225
    [Abstract] [Full Text] [Related]

  • 3. [Combined pertussis-tetanus-diphtheria-polio vaccine. Laboratory tests].
    Schiller B, Grodzicka WB, Rudnicka W.
    Med Dosw Mikrobiol; 1973; 25(3):231-8. PubMed ID: 4760226
    [No Abstract] [Full Text] [Related]

  • 4. Bacterial vaccines and toxoids: review of safety and efficacy.
    Stollerman GH.
    Adv Intern Med; 1978; 23():405-34. PubMed ID: 24328
    [No Abstract] [Full Text] [Related]

  • 5. Studies on the minimal number of animals required to achieve assurance of satisfactory potency in diphtheria and tetanus vaccines.
    Knight PA, Roberts PA.
    Dev Biol Stand; 1986; 65():245-53. PubMed ID: 3493931
    [Abstract] [Full Text] [Related]

  • 6. Report of an informal meeting about alternative methods for the potency control of the diphtheria and tetanus components in vaccines.
    Kreeftenberg JG.
    Dev Biol Stand; 1986; 65():261-6. PubMed ID: 3493932
    [Abstract] [Full Text] [Related]

  • 7. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S, Vulchev V, Bachev S.
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract] [Full Text] [Related]

  • 8. Development of a mouse model to estimate the potency of the diphtheria toxoid component of diphtheria-tetanus and diphtheria-tetanus-pertussis vaccines.
    Maheshwari SC, Sharma SB, Ahuja S, Saxena SN.
    J Biol Stand; 1988 Jul; 16(3):139-46. PubMed ID: 3170614
    [Abstract] [Full Text] [Related]

  • 9. The reduction of animal usage by the application of indirect haemagglutination in the potency testing of diphtheria toxoid in combined vaccines.
    Maheshwari SC, Sharma SB, Ahuja S, Saxena SN.
    J Biol Stand; 1988 Jan; 16(1):9-14. PubMed ID: 3258309
    [Abstract] [Full Text] [Related]

  • 10. Collaborative study: Standardization of Japanese reference diphtheria and tetanus toxoids, (adsorbed, lot 2), for potency determination of diphtheria-tetanus- acellular pertussis combined vaccine.
    Iwaki M, Komiya T, Fukuda T, Arakawa Y, Takahashi M.
    Jpn J Infect Dis; 2003 Aug; 56(4):183-5. PubMed ID: 14583650
    [No Abstract] [Full Text] [Related]

  • 11. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC, Sharma SB, Kumar A, Sokhey J.
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [Abstract] [Full Text] [Related]

  • 12. The results of study of pertussis component of DPT vaccine produced in USSR and some other countries.
    Zakharova MS, Malivanova OM, Sokolovskaya AD, Shavrova EN, Kapustik LA.
    J Hyg Epidemiol Microbiol Immunol; 1981 Sep; 25(4):439-48. PubMed ID: 7320507
    [Abstract] [Full Text] [Related]

  • 13. A comparison of combined diphtheria, tetanus and pertussis vaccines produced by different manufacturers, in laboratory animals and in infants.
    Nyerges G, Adám MM, Gács P, Ring R.
    J Biol Stand; 1986 Jul; 14(3):241-7. PubMed ID: 3489716
    [Abstract] [Full Text] [Related]

  • 14. Letter: Triple vaccine.
    Indian Pediatr; 1974 Nov; 11(11):763-4. PubMed ID: 4443052
    [No Abstract] [Full Text] [Related]

  • 15. Quadruple vaccines containing pertussis and poliomyelitis vaccines.
    Anderson GR, Gottshall RY, Nelsom E, Angela F.
    Health Lab Sci; 1978 Jul; 15(3):138-43. PubMed ID: 568123
    [Abstract] [Full Text] [Related]

  • 16. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK, Siber GR.
    Dev Biol Stand; 1996 Jul; 86():207-15. PubMed ID: 8785950
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The determination of the protective potency of the diphtheria component in combined vaccines by the indirect hemagglutination (IHA) method].
    Unver SD, Ozcengiz E.
    Mikrobiyol Bul; 1990 Oct; 24(4):327-35. PubMed ID: 2287290
    [Abstract] [Full Text] [Related]

  • 19. A collaborative investigation of a potency assay for adsorbed tetanus vaccines based on the protection of mice from tetanic paralysis.
    Mussett MV, Sheffield F.
    J Biol Stand; 1976 Apr; 4(2):141-8. PubMed ID: 932045
    [No Abstract] [Full Text] [Related]

  • 20. [Improvement of methods of control of the harmlessness of whooping-cough and DPT vaccines].
    Chuprinina RP.
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Apr; (4):126-7. PubMed ID: 1221713
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.